Tag Archives: BACE

The Sharing Economy: Pharma Version

The Twenty-First Century ‘Sharing Economy’ has achieved a high profile and been sometimes rewarded with massive valuations over the past few years, with AirBnB and Uber epitomizing the model of sharing the costs and benefits associated with an asset. The … Continue reading

Posted in Big Pharma, Biotech | Tagged , , , , , | Leave a comment

AstraZeneca: Good News, Bad News (revised)

(Correction in paragraph 3, regarding Targacept): The press coverage today was all about AZ’s decision to advance their BACEi for Alzheimer’s, AZD3293, into a Phase II/III trial that, if highly successful, could in theory serve as a single trial for … Continue reading

Posted in Big Pharma | Tagged , , , | Leave a comment

Lilly and BACE

The termination of LY2886721, Lilly’s BACE inhibitor, probably reverberates louder than it should because it occurs in the context of a seemingly unremitting drumbeat of Alzheimer’s program failures.But Lilly’s statement that they think it was the molecule itself at fault … Continue reading

Posted in Big Pharma, Science | Tagged , , , , | Leave a comment